Cargando…

Virtual Screening and Biological Activity Evaluation of New Potent Inhibitors Targeting Hexokinase-II

Hexokinase-II (HK-II), the rate-limiting step enzyme in the glycolysis pathway, expresses high levels of cancer cells compared with normal cells. Due to its pivotal role in the different aspects of cancer physiology including cellular proliferation, metastasis, and apoptosis, HK-II provides a new th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ruijuan, Liu, Xuewei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658052/ https://www.ncbi.nlm.nih.gov/pubmed/36364382 http://dx.doi.org/10.3390/molecules27217555

Ejemplares similares

Virtual Screening for Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics
por: Tanbin, Suriyea, et al.
Publicado: (2020)

Discovery of potent STAT3 inhibitors using structure-based virtual screening, molecular dynamic simulation, and biological evaluation
por: Liu, Weifeng, et al.
Publicado: (2023)

Discovery of potent and noncovalent KRAS(G12D) inhibitors: Structure-based virtual screening and biological evaluation
por: Wang, Yuting, et al.
Publicado: (2022)

New classes of potent heparanase inhibitors from ligand-based virtual screening
por: Pala, Daniele, et al.
Publicado: (2020)

Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction
por: Barakat, Khaled H., et al.
Publicado: (2012)

Discovery of New α-Glucosidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation
por: Liu, Shan-Kui, et al.
Publicado: (2021)

The discovery of a novel compound with potent antitumor activity: virtual screening, synthesis, biological evaluation and preliminary mechanism study
por: Jin, Yuanyuan, et al.
Publicado: (2017)

A Target-Based High Throughput Screen Yields Trypanosoma brucei Hexokinase Small Molecule Inhibitors with Antiparasitic Activity
por: Sharlow, Elizabeth R., et al.
Publicado: (2010)

The Discovery of Highly Potent THP Derivatives as OCTN2 Inhibitors: From Structure-Based Virtual Screening to In Vivo Biological Activity
por: Di Cristo, Francesca, et al.
Publicado: (2020)

Virtual Screening and Biological Evaluation of Piperazine Derivatives as Human Acetylcholinesterase Inhibitors
por: Varadaraju, Kavitha Raj, et al.
Publicado: (2013)

Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation
por: Xu, Yonghua, et al.
Publicado: (2023)

Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2
por: Li, Wei, et al.
Publicado: (2017)

Structure-Based Virtual Screening and Biological Evaluation of Peptide Inhibitors for Polo-Box Domain
por: Yan, Fang, et al.
Publicado: (2019)

Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma
por: Zhong, Jiang-Tao, et al.
Publicado: (2016)

Potassium ions promote hexokinase-II dependent glycolysis
por: Bischof, Helmut, et al.
Publicado: (2021)

Potassium ions promote hexokinase-II dependent glycolysis
por: Bischof, Helmut, et al.
Publicado: (2021)

Homology Modeling and Virtual Screening to Discover Potent Inhibitors Targeting the Imidazole Glycerophosphate Dehydratase Protein in Staphylococcus xylosus
por: Chen, Xing-Ru, et al.
Publicado: (2017)

Virtual Screening, Synthesis and Biological Evaluation of Streptococcus mutans Mediated Biofilm Inhibitors
por: Atta, Lubna, et al.
Publicado: (2022)

Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays
por: Chen, Ying, et al.
Publicado: (2023)

Virtual screening and activity evaluation of multitargeting inhibitors for idiopathic pulmonary fibrosis
por: Wang, Rui, et al.
Publicado: (2022)

Identification of Potent VEGF Inhibitors for the Clinical Treatment of Glioblastoma, A Virtual Screening Approach
por: Yadav, Mohini, et al.
Publicado: (2019)

Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells
por: Zhang, Qianwen, et al.
Publicado: (2014)

Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2016)

Hexokinase II–derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells
por: Woldetsadik, Abiy D., et al.
Publicado: (2017)

Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis
por: Liu, Wenbin, et al.
Publicado: (2019)

Identification by shape-based virtual screening and evaluation of new tyrosinase inhibitors
por: Li, Qi, et al.
Publicado: (2018)

Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors
por: Lin, Tony Eight, et al.
Publicado: (2021)

Design, synthesis and biological evaluation of novel 1H-1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors viafragment-based virtual screening
por: Liu, Jian, et al.
Publicado: (2019)

Hexokinase 2 as oncotarget
por: Patra, Krushna C., et al.
Publicado: (2013)

Targeting hexokinase 2 in castration-resistant prostate cancer
por: Deng, Yibin, et al.
Publicado: (2015)

Identification of novel and potent dual-targeting HDAC1/SPOP inhibitors using structure-based virtual screening, molecular dynamics simulation and evaluation of in vitro and in vivo antitumor activity
por: Yang, Yingxue, et al.
Publicado: (2023)

Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase
por: Messaoudi, Abdelmonaem, et al.
Publicado: (2013)

Ligand-Based and Docking-Based Virtual Screening of MDM2 Inhibitors as Potent Anticancer Agents
por: Li, Bing-Hui, et al.
Publicado: (2021)

Structure-based virtual screening of highly potent inhibitors of the nematode chitinase CeCht1
por: Chen, Wei, et al.
Publicado: (2021)

N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation
por: Li, Wei-Yi, et al.
Publicado: (2019)

Subcellular Localization of Hexokinases I and II Directs the Metabolic Fate of Glucose
por: John, Scott, et al.
Publicado: (2011)

Designing of dual inhibitors for GSK-3β and CDK5: Virtual screening and in vitro biological activities study
por: Xie, Hongbo, et al.
Publicado: (2017)

Virtual Screening and Biological Evaluation of Novel Low Molecular Weight Protein Tyrosine Phosphatase Inhibitor for the Treatment of Insulin Resistance
por: Feng, Bo, et al.
Publicado: (2023)

Discovery of novel inhibitors targeting nematode chitinase CeCht1: Virtual screening, biological evaluation, and molecular dynamics simulation
por: Shen, Shengqiang, et al.
Publicado: (2022)

A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers
por: Xu, Shili, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pb1sifjmcm489co5u6mthid8v7